Your browser doesn't support javascript.
loading
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
Tetzlaff, M T; Messina, J L; Stein, J E; Xu, X; Amaria, R N; Blank, C U; van de Wiel, B A; Ferguson, P M; Rawson, R V; Ross, M I; Spillane, A J; Gershenwald, J E; Saw, R P M; van Akkooi, A C J; van Houdt, W J; Mitchell, T C; Menzies, A M; Long, G V; Wargo, J A; Davies, M A; Prieto, V G; Taube, J M; Scolyer, R A.
Afiliação
  • Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: mtetzlaff@mdanderson.org.
  • Messina JL; Departments of Anatomic Pathology and Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.
  • Stein JE; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Xu X; Department of Pathology and Laboratory Medicine, The Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Amaria RN; Melanoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Blank CU; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van de Wiel BA; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Ferguson PM; Melanoma Institute of Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia.
  • Rawson RV; Melanoma Institute of Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia.
  • Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Spillane AJ; Melanoma Institute of Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Saw RPM; Melanoma Institute of Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia.
  • van Akkooi ACJ; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Houdt WJ; The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Mitchell TC; Department of Medicine, The Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Menzies AM; Melanoma Institute of Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Long GV; Melanoma Institute of Australia, The University of Sydney, Royal North Shore Hospital, Sydney, Australia.
  • Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Davies MA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Melanoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Cente
  • Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Dermatology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Taube JM; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, USA.
  • Scolyer RA; Melanoma Institute of Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia.
Ann Oncol ; 29(8): 1861-1868, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29945191

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Patologia / Pele / Neoplasias Cutâneas / Linfonodos / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Patologia / Pele / Neoplasias Cutâneas / Linfonodos / Melanoma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article